Pseudopolymorphic Forms Of A Hiv Protease Inhibitor

Patent No. EP2767539 (titled "Pseudopolymorphic Forms Of A Hiv Protease Inhibitor") was filed by Janssen R&D Ireland on May 16, 2003. The application was issued on Jul 12, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
COOKEApr 12, 2018ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2767539

JANSSEN R&D IRELAND
Application Number
EP14168686A
Filing Date
May 16, 2003
Status
Opposition Rejected
Feb 10, 2023
Publication Date
Jul 12, 2017